These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 22091929)

  • 21. Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.
    Maradiegue A; Jasperson K; Edwards QT; Lowstuter K; Weitzel J
    J Am Acad Nurse Pract; 2008 Feb; 20(2):76-84. PubMed ID: 18271762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome.
    Shulman LP
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):109-33, Table of Contents. PubMed ID: 20494261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How often do BRCA mutation carriers tell their young children of the family's risk for cancer? A study of parental disclosure of BRCA mutations to minors and young adults.
    Bradbury AR; Dignam JJ; Ibe CN; Auh SL; Hlubocky FJ; Cummings SA; White M; Olopade OI; Daugherty CK
    J Clin Oncol; 2007 Aug; 25(24):3705-11. PubMed ID: 17704419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell.
    Patenaude AF; Dorval M; DiGianni LS; Schneider KA; Chittenden A; Garber JE
    J Clin Oncol; 2006 Feb; 24(4):700-6. PubMed ID: 16446344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uptake of offer to receive genetic information about BRCA1 and BRCA2 mutations in an Australian population-based study.
    Keogh LA; Southey MC; Maskiell J; Young MA; Gaff CL; Kirk J; Tucker KM; Rosenthal D; McCredie MR; Giles GG; Hopper JL
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2258-63. PubMed ID: 15598789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Challenges in the diagnosis and management of Lynch Syndrome in an Indigenous family living in a remote West Australian community.
    Schofield L; Goldblatt J; Iacopetta B
    Rural Remote Health; 2011; 11(4):1836. PubMed ID: 22188021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing.
    Lodder L; Frets PG; Trijsburg RW; Tibben A; Meijers-Heijboer EJ; Duivenvoorden HJ; Wagner A; van Der Meer CA; Devilee P; Cornelisse CJ; Niermeijer MF
    Eur J Hum Genet; 2001 Jul; 9(7):492-500. PubMed ID: 11464240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk for BRCA-1 or BRCA-2 mutation.
    Stolier AJ; Fuhrman GM; Mauterer L; Bolton JS; Superneau DW
    Breast J; 2004; 10(6):475-80. PubMed ID: 15569201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Understanding Lynch syndrome: implications for nursing.
    Bannon E; Coleman EA
    Clin J Oncol Nurs; 2007 Jun; 11(3):423-7. PubMed ID: 17623626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer.
    Gritz ER; Peterson SK; Vernon SW; Marani SK; Baile WF; Watts BG; Amos CI; Frazier ML; Lynch PM
    J Clin Oncol; 2005 Mar; 23(9):1902-10. PubMed ID: 15774782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does enhanced information at cancer genetic counseling improve counselees' knowledge, risk perception, satisfaction and negotiation of information to at-risk relatives?--a randomized study.
    Roshanai AH; Rosenquist R; Lampic C; Nordin K
    Acta Oncol; 2009; 48(7):999-1009. PubMed ID: 19636983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive genetic testing for hereditary non-polyposis colorectal cancer: uptake and long-term satisfaction.
    Aktan-Collan K; Mecklin JP; Järvinen H; Nyström-Lahti M; Peltomäki P; Söderling I; Uutela A; de la Chapelle A; Kääriäinen H
    Int J Cancer; 2000 Jan; 89(1):44-50. PubMed ID: 10719730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a counselling protocol for predictive genetic testing for hereditary non-polyposis colorectal cancer.
    Aktan-Collan K; Mecklin JP; de la Chapelle A; Peltomäki P; Uutela A; Kääriäinen H
    J Med Genet; 2000 Feb; 37(2):108-13. PubMed ID: 10662810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized trial of a shared decision-making intervention consisting of trade-offs and individualized treatment information for BRCA1/2 mutation carriers.
    van Roosmalen MS; Stalmeier PF; Verhoef LC; Hoekstra-Weebers JE; Oosterwijk JC; Hoogerbrugge N; Moog U; van Daal WA
    J Clin Oncol; 2004 Aug; 22(16):3293-301. PubMed ID: 15310772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program's experience.
    Wagner Costalas J; Itzen M; Malick J; Babb JS; Bove B; Godwin AK; Daly MB
    Am J Med Genet C Semin Med Genet; 2003 May; 119C(1):11-8. PubMed ID: 12704633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients.
    Schwartz MD; Lerman C; Brogan B; Peshkin BN; Isaacs C; DeMarco T; Halbert CH; Pennanen M; Finch C
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1003-7. PubMed ID: 15824179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Telephoned BRCA1/2 genetic test results: prevalence, practice, and patient satisfaction.
    Baumanis L; Evans JP; Callanan N; Susswein LR
    J Genet Couns; 2009 Oct; 18(5):447-63. PubMed ID: 19462222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic testing for maturity onset diabetes of the young: uptake, attitudes and comparison with hereditary non-polyposis colorectal cancer.
    Liljeström B; Aktan-Collan K; Isomaa B; Sarelin L; Uutela A; Groop L; Kääriäinen H; Tuomi T
    Diabetologia; 2005 Feb; 48(2):242-50. PubMed ID: 15660263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pre-visit website with question prompt sheet for counselees facilitates communication in the first consultation for breast cancer genetic counseling: findings from a randomized controlled trial.
    Albada A; van Dulmen S; Ausems MG; Bensing JM
    Genet Med; 2012 May; 14(5):535-42. PubMed ID: 22241101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proband-mediated interventions to increase disclosure of genetic risk in families with a BRCA or Lynch syndrome condition: a systematic review.
    Young AL; Imran A; Spoelma MJ; Williams R; Tucker KM; Halliday J; Forrest LE; Wakefield CE; Butow PN
    Eur J Hum Genet; 2023 Jan; 31(1):18-34. PubMed ID: 36253533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.